Transfer RM10,000 or more in shares to receive 2% Match Rewards, with up to RM100,000 in Nvidia shares up for grabs!​ ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Fidelity and Webull both offer impressive investing ...

The main difference between TradeStation and Webull is that TradeStation offers advanced trading tools and features for experienced traders, while Webull provides a more beginner-friendly, ...

BULL stock has lost about 91% of its value from its 52-week high of $79.56. ・On Jan. 27, Webull announced that it has ...

OCALA, Fla., Feb. 06, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today that it will participate in the Corporate Connect Webinar Series hosted by ...

Webull Corporation (NASDAQ:BULL) shares are trading higher Thursday after the company announced it will reintroduce crypto trading to its global customer base and integrate Webull Pay back into Webull ...

These days you don’t have to pay a penny in commissions to trade stocks or ETFs or fork over a dime to access investment research and portfolio management tools. It’s the perks that’ll cost you extra.

In late January 2026, Webull Financial LLC highlighted its expanding partnership with CFTC-regulated Kalshi, offering users sports and Big Game prediction markets with $0 commission on select event ...

Webull did not issue formal forward guidance in this release. Instead, the company emphasized continued investment in global expansion, AI, and new products, suggesting confidence in sustaining ...

Rosenblatt Securities has issued a buy rating on Webull (NASDAQ: BULL), arguing that its 28% drop over the last three months presents a buying opportunity before the company reports its Q4 earnings.

Akari Therapeutics, Plc (Nasdaq: AKTX ), an oncology biotechnology company pioneering next-generation antibody drug ...

Decoy Therapeutics, Inc. (Nasdaq: DCOY) (Decoy, or the Company), a preclinical biopharmaceutical that is engineering the next generation of peptide conjugate therapeutics, today announced that it will ...